Orforglipron, an oral non‐peptide glucagon‐like peptide‐1 receptor agonist, improves markers of β‐cell function and insulin sensitivity in type 2 diabetes

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Julio Rosenstock, Deborah A. Robins, Kevin L. Duffin, Jonathan M. Wilson, Yanzhu Lin, Hiya Banerjee, Sarah Eyde, Christof Kazda, Manige Konig, Kieren J. Mather
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items